Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Treatment of experimental equine osteoarthritis by in vivo delivery of the equine interleukin-1 receptor antagonist gene

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Frisbie, D. D.
  • Ghivizzani, S. C.
  • Robbins, Paul D.
  • Evans, C. H.
  • McIlwraith, C. W.

publication date

  • January 2002

journal

  • Gene Therapy  Journal

abstract

  • Osteoarthritis in horses and in humans is a significant social and economic problem and continued research and improvements in therapy are needed. Because horses have naturally occurring osteoarthritis, which is similar to that of humans, the horse was chosen as a species with which to investigate gene transfer as a potential therapeutic modality for the clinical treatment of osteoarthritis. Using an established model of equine osteoarthritis that mimics clinical osteoarthritis, the therapeutic effects resulting from intra-articular overexpression of the equine interleukin-1 receptor antagonist gene through adenoviral-mediated gene transfer were investigated. In vivo delivery of the equine IL-IRa gene led to elevated intra-articular expression of interleukin-1 receptor antagonist for approximately 28 days, resulting in significant improvement in clinical parameters of pain and disease activity, preservation of articular cartilage, and beneficial effects on the histologic parameters of synovial membrane and articular cartilage. Based on these findings, gene transfer of interleukin-1 receptor antagonist is an attractive treatment modality for the equine patient and also offers future promise for human patients with osteoarthritis.

subject areas

  • Adenoviridae
  • Analysis of Variance
  • Animals
  • Gene Expression
  • Genetic Therapy
  • Genetic Vectors
  • Horse Diseases
  • Horses
  • Injections, Intra-Articular
  • Models, Animal
  • Osteoarthritis
  • Receptors, Interleukin-1
  • Transduction, Genetic
scroll to property group menus

Research

keywords

  • equine
  • gene therapy
  • in vivo
  • interleukin-1 receptor antagonist
  • osteoarthritis
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0969-7128

Digital Object Identifier (DOI)

  • 10.1038/sj.gt.3301608

PubMed ID

  • 11850718
scroll to property group menus

Additional Document Info

start page

  • 12

end page

  • 20

volume

  • 9

issue

  • 1

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support